An improved LC-ESI-MS-MS method for simultaneous quantitation of rosiglitazone and N-desmethyl rosiglitazone in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 3, 2008, Pages 934-939

  O'Maille, Grace ^a   Pai, Sudhakar M ^a   Tao, Xiaolu ^a   Douglas Jr , George T ^b   Jenkins, Rand G ^b  

^a Akros Pharma Inc   (United States)

^b Pharmaceutical Product Development   (United States)

Author keywords

Human plasma; LC ESI MS MS; N desmethyl rosiglitazone; Rosiglitazone

Indexed keywords

NORROSIGLITAZONE; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

CALIBRATION; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HUMANS; HYPOGLYCEMIC AGENTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; THIAZOLIDINEDIONES;

EID: 53049103982     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.08.001     Document Type: Article

References (15)

1. Patel J., Miller E., Patwardhan R., et al. Diabetes 47 (1998) A17
2. Ashiya M., and Smith R.E.T. Nat. Rev. Drug Discov. 6 (2007) 777-778
3. Baldwin S.J., Clarke S.E., and Chenery R.J. Br. J. Clin. Pharmacol. 48 (1999) 424-432
4. Cox P.J., Ryan D.A., Hollis F.J., Harris A.-M., Miller A.K., Vousden M., and Ley H.C. Drug Metab. Dispos. 28 (2000) 772-780
5. Drug Interaction Studies. Study design, data analysis, and implications for dosing and labeling. Draft Guidance, September 2006, FDA (CEDR, CBER). http://www.fda.gov/cder/guidance/6695dft.htm.
6. Niemi M., Backman J.T., and Neuvonen P.J. Clin. Pharmacol. Ther. 76 (2004) 239-249
7. Hruska M.W., Amico J.A., Langaee T.Y., Ferrell R.E., Fitzgerald S.M., and Frye R.F. Br. J. Clin. Pharmacol. 59 (2005) 70-79
8. He J., Hu Y.F., Duan L.F., Tan Z.R., Wang L.S., Wang D., Zhang W., Li Z., Liu J., Tu J.H., Yao Y.M., and Zhou H.-H. J. Pharm. Biomed. Anal. 43 (2007) 580-585
9. Muxlow A.M., Fowles S., and Russell P. J. Chromatogr. B Biomed. Sci. Appl. 752 (2001) 77-84
10. Mamidi R.N.V.S., Chaluvadi M.R., Benjamin B., Ramesh M., Katneni K., Babu A.P., Bhanduri J., Rao N.M.U., and Rajagopalan R. Arzneim. -Forsch. 52 (2002) 560-564
11. Radhakrishna T., Satyanarayana J., and Satyanarayana A. J. Pharm. Biomed. Anal. 29 (2002) 873-880
12. Hruska M.W., and Frye R.F. J. Chromatogr. B 803 (2004) 317-320
13. Kim K.-A., and Park J.-Y. Biomed. Chromatogr. 18 (2004) 613-615
14. Kolte B.L., Raut B.B., Deo A.A., Bagool M.A., and Shinde D.B. J. Chromatogr. Sci. 42 (2004) 70-73
15. Pedersen R.S., Brosen K., and Nielsen F. Chromatographia 62 (2005) 197-201